SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-021871
Filing Date
2024-02-01
Accepted
2024-02-01 16:20:32
Documents
14
Period of Report
2024-01-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d745810d8k.htm   iXBRL 8-K 20955
  Complete submission text file 0001193125-24-021871.txt   138275

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gh-20240126.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240126_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240126_pre.xml EX-101.PRE 10815
15 EXTRACTED XBRL INSTANCE DOCUMENT d745810d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 24587221
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)